Advertisement

Topics

Otsuka’s Avanir Encouraged By First Peek At Treatment For Alzheimer’s Agitation

08:28 EDT 26 Mar 2019 | SCRIP

Phase III results from Avanir’s candidate for agitation in patients with Alzheimer’s disease offers some hope in a setting for...

      

Related Stories

 

Original Article: Otsuka’s Avanir Encouraged By First Peek At Treatment For Alzheimer’s Agitation

NEXT ARTICLE

More From BioPortfolio on "Otsuka’s Avanir Encouraged By First Peek At Treatment For Alzheimer’s Agitation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...